Genetic Markers for Estrogen Receptor-Negative Breast Cancer
Author Information
Author(s): Li Jingmei, Humphreys Keith, Darabi Hatef, Rosin Gustaf, Hannelius Ulf, Heikkinen Tuomas, Aittomäki Kristiina, Blomqvist Carl, Pharoah Paul DP, Dunning Alison M, Ahmed Shahana, Hooning Maartje J, Hollestelle Antoinette, Oldenburg Rogier A, Alfredsson Lars, Palotie Aarno, Peltonen-Palotie Leena, Irwanto Astrid, Low Hui Qi, Teoh Garrett HK, Thalamuthu Anbupalam, Kere Juha, D'Amato Mauro, Easton Douglas F, Nevanlinna Heli, Liu Jianjun, Czene Kamila, Hall Per
Primary Institution: Karolinska Institutet
Hypothesis
What genetic markers are associated with the risk of estrogen receptor-negative breast cancer?
Conclusion
ER-negative breast cancer is a distinct subtype that requires independent analysis due to its unique genetic characteristics.
Supporting Evidence
- ER-negative breast cancer is characterized by lower age of onset and a more aggressive disease course.
- Approximately one-third of all breast cancers are ER-negative.
- Genetic effect sizes for ER-negative breast cancer are likely small, necessitating larger sample sizes for future studies.
Takeaway
This study looked at the genes that might make people more likely to get a specific type of breast cancer that doesn't respond to certain treatments. They found that this type of cancer is different from others and needs more research.
Methodology
The study analyzed 285,984 SNPs in 617 ER-negative breast cancer cases and 4,583 controls using genome-wide association analysis.
Potential Biases
Potential biases due to population stratification and the use of different genotyping platforms.
Limitations
The study had limited statistical power and the associations observed were only nominally significant.
Participant Demographics
Participants included 617 ER-negative breast cancer cases and 4,583 controls from Sweden and Finland.
Statistical Information
P-Value
3.13 × 10-13
Confidence Interval
95% CI: 0.93 to 1.13
Statistical Significance
p=0.052
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website